|
| Current indications |
|
| Recurrent severe hypoglycemia |
| Wide fluctuations in blood glucose levels regardless of HbA1c |
| Suboptimal diabetes control |
| Microvascular complications and/or risk factors for macrovascular complications |
| Good metabolic control but insulin regimen that compromises lifestyle (e.g., competitive athletes and needle phobia) |
| Adolescents with eating disorders |
| Children and adolescents with a pronounced dawn phenomenon |
| Ketosis-prone individuals |
|
| Advantages of CSII compared with MDI in children |
|
| Easier and convenient adjustment of bolus insulin dose and nocturnal basal insulin dose |
| Greater accuracy of insulin dosage |
| Easier management of infectious illnesses and hyperglycemic episodes |
| Quality of life improvement |
| Less injections Less anxiety better compliance |
| Flexibility of everyday activities |
|